BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 27678431)

  • 1. Familial hypercholesterolemia among unselected contemporary patients presenting with first myocardial infarction: Prevalence, risk factor burden, and impact on age at presentation.
    Mortensen MB; Kulenovic I; Klausen IC; Falk E
    J Clin Lipidol; 2016; 10(5):1145-1152.e1. PubMed ID: 27678431
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of familial hypercholesterolemia in patients with myocardial infarction: A Chinese cohort study.
    Li S; Zhang Y; Zhu CG; Guo YL; Wu NQ; Gao Y; Qing P; Li XL; Sun J; Liu G; Dong Q; Xu RX; Cui CJ; Li JJ
    J Clin Lipidol; 2016; 10(6):1344-1352. PubMed ID: 27919351
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of clinical familial hypercholesterolaemia among patients with high cholesterol levels.
    Martinsen MH; Hedegaard BS; Klausen IC; Mortensen MB
    Dan Med J; 2019 Nov; 66(11):. PubMed ID: 31686647
    [TBL] [Abstract][Full Text] [Related]  

  • 4. US physician practices for diagnosing familial hypercholesterolemia: data from the CASCADE-FH registry.
    Ahmad ZS; Andersen RL; Andersen LH; O'Brien EC; Kindt I; Shrader P; Vasandani C; Newman CB; deGoma EM; Baum SJ; Hemphill LC; Hudgins LC; Ahmed CD; Kullo IJ; Gidding SS; Duffy D; Neal W; Wilemon K; Roe MT; Rader DJ; Ballantyne CM; Linton MF; Duell PB; Shapiro MD; Moriarty PM; Knowles JW
    J Clin Lipidol; 2016; 10(5):1223-9. PubMed ID: 27678440
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Prevalence and clinical features of familial hypercholesterolemia in Chinese patients with myocardial infarction].
    Sun D; Li S; Zhu CG; Guo YL; Wu NQ; Gao Y; Qing P; Zhang Y; Liu G; Dong Q; Li JJ
    Zhonghua Xin Xue Guan Bing Za Zhi; 2018 Feb; 46(2):109-113. PubMed ID: 29495233
    [No Abstract]   [Full Text] [Related]  

  • 6. Genetically Confirmed Familial Hypercholesterolemia in Patients With Acute Coronary Syndrome.
    Amor-Salamanca A; Castillo S; Gonzalez-Vioque E; Dominguez F; Quintana L; Lluís-Ganella C; Escudier JM; Ortega J; Lara-Pezzi E; Alonso-Pulpon L; Garcia-Pavia P
    J Am Coll Cardiol; 2017 Oct; 70(14):1732-1740. PubMed ID: 28958330
    [TBL] [Abstract][Full Text] [Related]  

  • 7. How To Identify Familial Premature Myocardial Infarction: Comparing Approaches To Identify Familial Hypercholesterolemia.
    Beheshti S; Madsen CM; Varbo A; Nordestgaard BG
    J Clin Endocrinol Metab; 2019 Jul; 104(7):2657-2667. PubMed ID: 30753598
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DIAgnosis and Management Of familial hypercholesterolemia in a Nationwide Design (DIAMOND-FH): Prevalence in Switzerland, clinical characteristics and the diagnostic value of clinical scores.
    Miserez AR; Martin FJ; Spirk D
    Atherosclerosis; 2018 Oct; 277():282-288. PubMed ID: 30270060
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of familial hypercholesterolemia in patients with premature myocardial infarction.
    Cui Y; Li S; Zhang F; Song J; Lee C; Wu M; Chen H
    Clin Cardiol; 2019 Mar; 42(3):385-390. PubMed ID: 30637778
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of familial hypercholesterolemia in premature coronary artery disease patients admitted to a tertiary care hospital in North India.
    Sawhney JPS; Prasad SR; Sharma M; Madan K; Mohanty A; Passey R; Mehta A; Kandpal B; Makhija A; Jain R; Mantri RR; Vivek BS; Manchanda SC; Verma IC
    Indian Heart J; 2019; 71(2):118-122. PubMed ID: 31280822
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence and pharmacologic management of familial hypercholesterolemia in an unselected contemporary cohort of patients with stable coronary artery disease.
    De Luca L; Arca M; Temporelli PL; Colivicchi F; Gonzini L; Lucci D; Bosco B; Callerame M; Lettica GV; Di Lenarda A; Gulizia MM;
    Clin Cardiol; 2018 Aug; 41(8):1075-1083. PubMed ID: 30039543
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Applying an LDL-C threshold-based approach to identify individuals with familial hypercholesterolemia.
    Jasani R; Ahmad Z; Schneider R; Tujardon C; Basit M; Khera A
    J Clin Lipidol; 2022; 16(4):508-515. PubMed ID: 35568683
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence and management of familial hypercholesterolaemia in patients with acute coronary syndromes.
    Nanchen D; Gencer B; Auer R; Räber L; Stefanini GG; Klingenberg R; Schmied CM; Cornuz J; Muller O; Vogt P; Jüni P; Matter CM; Windecker S; Lüscher TF; Mach F; Rodondi N
    Eur Heart J; 2015 Sep; 36(36):2438-45. PubMed ID: 26142466
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence, risk factor burden, and severity of coronary artery disease in patients with heterozygous familial hypercholesterolemia hospitalized for an acute myocardial infarction: Data from the French RICO survey.
    Farnier M; Salignon-Vernay C; Yao H; Chague F; Brunel P; Maza M; Brunet D; Bichat F; Beer JC; Cottin Y; Zeller M
    J Clin Lipidol; 2019; 13(4):601-607. PubMed ID: 31324593
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Familial Hypercholesterolemia Among Young Adults With Myocardial Infarction.
    Singh A; Gupta A; Collins BL; Qamar A; Monda KL; Biery D; Lopez JAG; de Ferranti SD; Plutzky J; Cannon CP; Januzzi JL; Di Carli MF; Nasir K; Bhatt DL; Blankstein R
    J Am Coll Cardiol; 2019 May; 73(19):2439-2450. PubMed ID: 31097165
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Equivalent Impact of Elevated Lipoprotein(a) and Familial Hypercholesterolemia in Patients With Atherosclerotic Cardiovascular Disease.
    Hedegaard BS; Bork CS; Kaltoft M; Klausen IC; Schmidt EB; Kamstrup PR; Langsted A; Nordestgaard BG
    J Am Coll Cardiol; 2022 Nov; 80(21):1998-2010. PubMed ID: 36396201
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The prevalence and prognostic importance of possible familial hypercholesterolemia in patients with myocardial infarction.
    Rerup SA; Bang LE; Mogensen UM; Engstrøm T; Jørgensen E; Pedersen F; Torp-Pedersen C; Gislason G; James S; Hagström E; Køber L; Fosbøl EL
    Am Heart J; 2016 Nov; 181():35-42. PubMed ID: 27823691
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Application of expanded genetic analysis in the diagnosis of familial hypercholesterolemia in patients with very early-onset coronary artery disease.
    Cao YX; Wu NQ; Sun D; Liu HH; Jin JL; Li S; Guo YL; Zhu CG; Gao Y; Dong QT; Liu G; Dong Q; Li JJ
    J Transl Med; 2018 Dec; 16(1):345. PubMed ID: 30526649
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficiency and problems of statin therapy in patients with heterozygous familial hypercholesterolemia.
    Korneva V; Kuznetsova T; Julius U
    Atheroscler Suppl; 2019 Dec; 40():79-87. PubMed ID: 31818452
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of cardiovascular risk factors in patients with familial hypercholesterolemia from the North-Eastern area of Romania.
    Vlad CE; Foia L; Florea L; Costache II; Covic A; Popescu R; Reurean-Pintilei D; Covic A
    Lipids Health Dis; 2021 Jan; 20(1):4. PubMed ID: 33430859
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.